BRAF and melanoma: Differential abundance analysis in control SKMEL28-EV cells revealed significant depletion of BRAF and MAPK1 (also known as ERK2) targeting sgRNAs, in line with the known addiction of BRAFV600E mutant melanomas to the MAPK pathway (Fig. 3b and Supplementary Table 3).